Arab Health 2022 - Dubai World Trade Center

Arab Health 2022 – The unique experience full of innovative concepts, inspiring people and new connections, disruptive technologies and fascinating discoveries in healthcare, in the largest Middle Eastern healthcare exhibition.
It was four amazing days at the Dubai World Trade Center that resulted from a close collaboration between IGHS, Innov-Cell Therapeutics, Ciberbit and Ipotz Studio.
Ipotz and Ciberbit, Portuguese companies that collaborate with the IGHS Group in several hospital projects, and Innov-Cell Therapeutics, presented their products and services at the exhibition, reinforcing the focus on the Middle East market. 
The IGHS Group is currently participating in its own projects or third-party projects in Hong Kong, Macau, Qatar, Oman, Saudi Arabia and the United Arab Emirates, assuming the complementarity and sharing of competencies with several Portuguese companies as an important differentiation factor.  

Together we do it better!

• Innov.Cell ended its successful participation in CPHI 2024

  Innov.Cell, a subsidiary of IGHS, ended its successful participation in CPHI 2024, which took place in Milan, with a positive outcome. This year, CPHI was attended by more than 62,000 people and around 2,400 exhibitors from 166 countries. Throughout the event, Innov.Cell met with several potential partners, from R&D, investors, and distributors covering more than 50 countries.

  Read more
• OIH Introduces Revolutionary Treatment for Keratoconus: Corneal Allogeneic Intrastromal Ring Implants (CAIRS)

  Oman International Hospital is thrilled to announce the successful introduction of a groundbreaking procedure designed to treat keratoconus: Corneal Allogeneic Intrastromal Ring Implants (CAIRS). This innovative treatment marks a significant advancement in ophthalmology, offering new hope to patients suffering from this debilitating corneal disorder.
   

  Read more